METASTATIC COLORECTAL CARCINOMA (MCRC)
Clinical trials for METASTATIC COLORECTAL CARCINOMA (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CARCINOMA (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CARCINOMA (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes on hard-to-treat cancers
Disease control Not yet recruitingThis early-phase study tests a combination of two drugs, L19IL2 and ruxolitinib, in people with advanced kidney, pancreatic, or colorectal cancers that have stopped responding to standard treatments. The main goal is to find a safe dose and check for side effects. About 96 partic…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated May 26, 2026 08:18 UTC
-
New hope for advanced bowel cancer: ULYSSE trial launches
Disease control Not yet recruitingThis study tests a new drug, fruquintinib, combined with standard chemotherapy for people with metastatic colorectal cancer that has worsened after first treatment. About 74 adults aged 18 to 80 will be randomly assigned to receive either the new combination or the usual treatmen…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Blood filter aims to suck cancer cells out of patients with advanced tumors
Disease control Not yet recruitingThis study tests a device called ONCObind that filters blood to remove circulating tumor cells in patients with advanced pancreatic or colorectal cancer that has spread and is no longer responding to standard treatments. About 120 adults will receive the filter procedure multiple…
Matched conditions: METASTATIC COLORECTAL CARCINOMA (MCRC)
Phase: NA • Sponsor: ExThera Medical Corporation • Aim: Disease control
Last updated May 13, 2026 16:02 UTC